CIK 0001137883 · Non-accelerated filer<br>Smaller reporting company
BRAINSTORM CELL THERAPEUTICS INC.
Sign in to watch- Ticker
- BCLI
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 207273918
- Phone
- 201-488-0460
- Business address
- 1325 AVENUE OF AMERICAS, 28TH FLOOR, NEW YORK, NY, 10019
- Former names
- BRAINSTORM CELL THERAPEUTICS INC, GOLDEN HAND RESOURCES INC, WIZBANG TECHNOLOGIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-08-28 | ARBEL IRIT Director | Option exercise · Stock Option (right to buy) | −6,666 | 0 | ||
| 2019-07-26 | Lebovits Chaim See Remarks | Grant or award | +31,185 | 2,166,155 | ||
| 2019-03-06 | Kern Ralph Dr. COO and Chief Medical Officer | Grant or award | +35,885 | 112,655 | ||
| 2019-02-01 | Polverino Anthony J. Director | Grant or award | +3,501 | 10,791 | ||
| 2019-01-04 | Almenoff June Sherie Director | Purchase | +1,475 | $3.39 | $5K | 7,175 |
| 2018-10-24 | Schor Chen Director | Gift | −121,558 | 4,000 | ||
| 2018-10-24 | Schor Chen Director | Gift | +121,558 | 121,558 |
Page 7 of 7 · 127 trades